Leveraging the Treg-intrinsic CTLA4–PKCη signaling pathway for cancer immunotherapy
Crossref DOI link: https://doi.org/10.1136/jitc-2021-002792
Published Online: 2021-09-29
Published Print: 2021-09
Update policy: https://doi.org/10.1136/crossmarkpolicy
Liu, Hsin-Yu https://orcid.org/0000-0002-1637-5814
Pedros, Christophe
Kong, Kok-Fai
Canonigo-Balancio, Ann J
Xue, Wen
Altman, Amnon
Funding for this research was provided by:
Foundation for the National Institutes of Health (NIH grant CA233862)
License valid from 2021-09-29
